The Effect of Bcrp1 (Abcg2) on the <i>In vivo</i> Pharmacokinetics and Brain Penetration of Imatinib Mesylate (Gleevec): Implications for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in PatientsPauline Breedveld, Jan H.M. Schellens, Olaf van Tellingen et al.|Cancer Research|2005Cited by 351
Mechanism of the Pharmacokinetic Interaction between Methotrexate and BenzimidazolesPauline Breedveld, Jan H.M. Schellens, Noam Zelcer et al.|Cancer Research|2004Cited by 233